Publications by authors named "Jonas Halfvarson"

Claim this Profile
E
Environmental and Inflammatory Factors Drive Perinuclear-Antineutrophil Cytoplasmic Antibodies (pANCA) in Ulcerative Colitis: A European Twin Study.
Daniel Bergemalm, Karin Amcoff, Marie J Pierik, Jean-Frederic Colombel, Severine Vermeire, Jonas Halfvarson

United European Gastroenterol J· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First insights into microbial changes within an Inflammatory Bowel Disease Family Cohort study.
Philipp Rausch, Ilka Ratjen, Lukas Tittmann, Janna Enderle, Eike Matthias Wacker, Jonas Halfvarson

Gut Microbes· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of histologic and clinical activity with major adverse cardiovascular events in patients with inflammatory bowel disease: A cohort study.
Jiangwei Sun, Karl Mårild, Johan Sundström, David Bergman, , Jonas Halfvarson

J Intern Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of serious infections in patients with inflammatory bowel disease treated with biologic and small molecule therapies: A nationwide cohort study.
Jordan Axelrad, Anders Forss, Jonas Söderling, Karl Mårild, Jonas Halfvarson

J Crohns Colitis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gut Mycobiome in Inflammatory Bowel Disease: A Systematic Review of Case-Control Studies.
Johannes D Füchtbauer, Olga Brovkina, Kostas Sivickis, Claus Aalykke, Marte L Høivik, Jonas Halfvarson

Inflamm Bowel Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Disease Course of Crohn's Disease in a Prospective European Population-based Inception Cohort: An Epi-IBD Cohort Study.
Mads Damsgaard Wewer, Søren Lophaven, Peter L Lakatos, Lorant Gonczi, Riina Salupere, Jonas Halfvarson

Clin Gastroenterol Hepatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histologic Remission and Mortality in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study.
Jiangwei Sun, Karl Mårild, David Bergman, Fahim Ebrahimi, , Jonas Halfvarson

Clin Gastroenterol Hepatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory Bowel Disease, Periconceptional Disease Activity, and Risk of Major Congenital Anomalies: A Nationwide Cohort Study.
Karl Mårild, Jonas Söderling, Olof Stephansson, Jordan Axelrad, Jonas Halfvarson

Am J Gastroenterol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply.
Olle Grännö, Daniel Bergemalm, Benita Salomon, Jonas Halfvarson

Gastroenterology· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IBD Prediction Is Possible, but How Far Are We from Implementing It?
Williams Turpin, Hamed Kalili, Jonas Halfvarson, Kenneth Croitoru

Inflamm Bowel Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International consensus on the use of intestinal ultrasound in inflammatory bowel disease trials.
Mariangela Allocca, Vipul Jairath, Bruce E Sands, David T Rubin, Bénédicte Caron, Jonas Halfvarson

J Crohns Colitis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory bowel disease patients are at increased risk for interstitial lung diseases.
Bharati Kochar, Jiangwei Sun, Ola Olén, Jonas Halfvarson, Marcus Thuresson

Am J Gastroenterol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Magnetic Resonance Imaging Consensus for use in Luminal Crohn's Disease Trials and Clinical Practice.
Bénédicte Caron, Vipul Jairath, Bruce E Sands, David T Rubin, Mariangela Allocca, Jonas Halfvarson

Clin Gastroenterol Hepatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness of tofacitinib versus upadacitinib for the treatment of acute severe ulcerative colitis.
Sailish Honap, Joelle St-Pierre, Michael Colwill, Kamal Patel, Catherine Le Berre, Jonas Halfvarson

Clin Gastroenterol Hepatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult-onset inflammatory bowel disease and the risk of venous thromboembolism - a Swedish nationwide cohort study 2007-2021.
Gabriella Bröms, Anders Forss, Julia Eriksson, Johan Askling, Carl Eriksson, Jonas Halfvarson

Scand J Gastroenterol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Efficacy, Safety, and Immunogenicity of SDZ-ADL, an Adalimumab Biosimilar, in Biologic-Naïve and Switched Patients with Immune-Mediated Inflammatory Diseases: A Literature Review.
Piotr Wiland, Charlotte Both, Norman B Gaylis, Russell D Cohen, Jonas Halfvarson

Adv Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer incidence in patients with ulcerative colitis naïve to or treated with thiopurine and targeted therapies-a cohort study 2007 to 2022 with comparison to the general population.
Åsa H Everhov, Johan Askling, Jonas Söderling, Jonas Halfvarson, Julia Eriksson

J Crohns Colitis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term disease course of ulcerative colitis in a prospective European population-based inception cohort-an Epi-IBD cohort study.
Mads Damsgaard Wewer, Søren Lophaven, Peter L Lakatos, Lorant Gonczi, Riina Salupere, Jonas Halfvarson

J Crohns Colitis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective observational study of tofacitinib in ulcerative colitis - analysis of clinical data, fatigue and health-related quality of life during the induction phase.
Lisa Nyberg, Jonas Halfvarson, Jonas Söderling, Ola Olén, Hans Strid

Therap Adv Gastroenterol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-integrin αvβ6 IgG antibody as a diagnostic and prognostic marker in ulcerative colitis: A cross-sectional and longitudinal study defining a specific disease phenotype.
Eleftheria Pertsinidou, Benita Salomon, Daniel Bergemalm, Samira Salihovic, Charlotte R H Hedin, Jonas Halfvarson

J Crohns Colitis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cohort profile: the Swedish Inception Cohort in inflammatory bowel disease (SIC-IBD).
Benita Salomon, Olle Grännö, Daniel Bergemalm, Hans Strid, Adam Carstens, Jonas Halfvarson

BMJ Open· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microbial Patterns in Newly Diagnosed Inflammatory Bowel Disease Revealed by Presence and Transcriptional Activity - Relationship to Diagnosis and Outcome.
Simen Svendsen Vatn, Simen Hyll Hansen, Tone Møller Tannæs, Stephan Brackmann, Christine Olbjørn, Jonas Halfvarson

Clin Exp Gastroenterol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Definitions, diagnosis, and management of postoperative recurrence in Crohn's disease patients with permanent ileostomy-a systematic review and meta-analysis.
Suha Abushamma, Tesfaye Yadete, Neil Nero, Katherine Falloon, Claire E Parker, Jonas Halfvarson

J Crohns Colitis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cumulative incidence and prevalence of perianal diseases in patients with inflammatory bowel disease and in the population: a nationwide Swedish study.
Åsa H Everhov, Michael Eberhardson, Jonas Söderling, Caroline Nordenvall, Jonas Halfvarson

Scand J Gastroenterol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accelerating Earlier Access to Anti-TNF-α Agents with Biosimilar Medicines in the Management of Inflammatory Bowel Disease.
Gionata Fiorino, Ashwin Ananthakrishnan, Russell D Cohen, Raymond K Cross, Parakkal Deepak, Jonas Halfvarson

J Clin Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis